BioSpace News Archive

Publication also documents the ability to deliver targeted thrombolytic medication via IRRAflow’s recurring irrigation for the first time in peer-reviewed scientific literature

Sugemalimab is the first PD(L)1 monoclonal antibody to demonstrate a progression-free survival benefit in Stage III non-small cell lung cancer (NSCLC) patients after treatment with either concurrent or sequential chemoradiotherapy

Zhongchao Inc., a healthcare services company offering online healthcare information, professional training and educational services, announced the launch of the patient management service focusing on the professional field of tumor and rare disease operated through its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd..

Transparency Market Research in its new report predicts that the global metabolomics market will undergo a tremendous transformation in the near future.

Patient engagement solutions comprise various services, associated hardware, and healthcare information technology solutions.

TMR estimates that the healthcare cleanroom consumables market features fragmented and highly competitive vendor landscape.

Increasing approvals and government initiatives are encouraging biosimilar drugs production and are creating opportunities for growth in the fusion protein biosimilar market

If Approved by the FDA, PEDMARK Stands to Be the First Therapy for the Prevention of Cisplatin-Induced Hearing Loss in Children

Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, announced medtech veteran Kevin Collins has joined the company as Chief Revenue Officer with global revenue responsibility.